CATAFLAM

Serial Number 88713451
Registration 6349240
700

Registration Progress

Application Filed
Dec 3, 2019
Under Examination
Oct 6, 2020
Approved for Publication
Aug 11, 2020
Published for Opposition
Aug 11, 2020
Registered
May 11, 2021

Trademark Image

CATAFLAM

Basic Information

Serial Number
88713451
Registration Number
6349240
Filing Date
December 3, 2019
Registration Date
May 11, 2021
Published for Opposition
August 11, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 11, 2021
Registration
Registered
Classes
005

Rights Holder

AMICI PHARMA, INC.

03
Address
425 BROADHOLLOW ROAD
SUITE 315
MELVILLE, NY 11747

Ownership History

Amici Pharmaceuticals, LLC

Original Applicant
16
Melville, NY

Amici Pharmaceuticals, LLC

Owner at Publication
16
Melville, NY

Amici Pharmaceuticals, LLC

Original Registrant
16
Melville, NY

AMICI PHARMA, INC.

New Owner After Registration #1
03
MELVILLE, NY

Legal Representation

Attorney
Timothy D. Pecsenye

USPTO Deadlines

Next Deadline
478 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210511)
Due Date
May 11, 2027
Grace Period Ends
November 11, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Aug 22, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 11, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 9, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 8, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 24, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 3, 2021 IUAF S USE AMENDMENT FILED Loading...
Mar 22, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 3, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 6, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 11, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 6, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 15, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 15, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 15, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 4, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 4, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 7, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 6, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparation for the treatment of articular syndrome, degenerative and chronic inflammatory disease of musculoskeletal system, post-traumatic inflammation of soft tissue and muscluloskeletal system, pain in the spine, neuralgia, myalgia, arthralgia, pain and inflammation after surgery or injury, pain in gout, migraine, algomenorrhea, pain with Bursitis, proctitis, colic (biliary and renal), pain in infectious and inflammatory diseases of ENT organs, and inhibition of miosis during ocular surgery
First Use Anywhere: Dec 14, 2020
First Use in Commerce: Dec 14, 2020

Classification

International Classes
005